Feed 2181.HK
21
Mabpharm Limited
2181.HK · HKSE
$0.42 +0.00% (+$0.00)
1M -3.45%
Market Cap ¥1.5B
P/E Ratio 26.76x
Div. Yield -
ROE 48.36%
Bulios Fair Price
$0.57
35.7% upside
Trenutna cena
$0.42
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica 2181.HK trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Valuation
22 /100
Expensive EV/EBITDA 27.13x
P/S 2.37x
P/B 9.46x
Growth
78 /100
Growing Book val. growth 26.78%
Rev. growth 124.11%
FCF growth N/A
Profitability
33 /100
Weak Net margin 8.84%
Op. margin 0.74%
FCF margin 3.69%
Quality
61 /100
Average ROE 48.36%
ROA 4.82%
Asset turnover 0.55x
Debt
22 /100
High Current ratio 0.81x
Int. coverage 0.44x
Net debt/EBITDA 3.46x
Stability
30 /100
Unstable Rev. volatility 70.93%
EPS volatility 73.99%
Profitable years 1
Vprašajte StockBota o 2181.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hao Wang
Employees
389
Headquarters
Taizhou
Prihajajoči dogodki
21 AVG.
Earnings
Upcoming earnings report